{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:26:12Z","timestamp":1791246372246,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016230","name":"Steven and Alexandra Cohen Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016230","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014731","name":"Global Lyme Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013479","name":"Bay Area Lyme Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s15010-021-01590-0","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T19:02:27Z","timestamp":1615143747000},"page":"685-692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The presenting characteristics of erythema migrans vary by age, sex, duration, and body location"],"prefix":"10.1007","volume":"49","author":[{"given":"Alison W.","family":"Rebman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica A.","family":"Mihm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl B.","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2648-0896","authenticated-orcid":false,"given":"John N.","family":"Aucott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,7]]},"reference":[{"key":"1590_CR1","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","volume":"2","author":"AC Steere","year":"2016","unstructured":"Steere AC, Strle F, Wormser GP, Hu LT, Branda JA, Hovius JW, et al. Lyme borreliosis. Nat Rev Dis Prim. 2016;2:16090.","journal-title":"Nat Rev Dis Prim"},{"key":"1590_CR2","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1056\/NEJM200306123482423","volume":"348","author":"AC Steere","year":"2003","unstructured":"Steere AC, Sikand VK. The presenting manifestations of Lyme disease and the outcomes of treatment. N Engl J Med. 2003;348:2472\u20134.","journal-title":"N Engl J Med"},{"key":"1590_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/infdis\/jix563","volume":"217","author":"A Marques","year":"2018","unstructured":"Marques A, Schwartz I, Wormser GP, Wang Y, Hornung RL, Demirkale CY, et al. Transcriptome assessment of erythema migrans skin lesions in patients with early Lyme disease reveals predominant interferon signaling. J Infect Dis. 2018;217:158\u201367.","journal-title":"J Infect Dis"},{"key":"1590_CR4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0002-9343(95)99915-9","volume":"100","author":"RB Nadelman","year":"1996","unstructured":"Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D, et al. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med. 1996;100:502\u20138.","journal-title":"Am J Med"},{"key":"1590_CR5","doi-asserted-by":"publisher","first-page":"751","DOI":"10.7326\/0003-4819-142-9-200505030-00011","volume":"142","author":"GP Wormser","year":"2005","unstructured":"Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D, et al. Brief communication: hematogenous dissemination in early Lyme disease. Ann Intern Med. 2005;142:751\u20135.","journal-title":"Ann Intern Med"},{"key":"1590_CR6","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1001\/jama.297.23.2617","volume":"297","author":"CD Tibbles","year":"2007","unstructured":"Tibbles CD, Edlow JA. Does this patient have erythema migrans? JAMA. 2007;297:2617\u201327.","journal-title":"JAMA"},{"key":"1590_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.idc.2015.02.001","volume":"29","author":"RB Nadelman","year":"2015","unstructured":"Nadelman RB. Erythema migrans. Infect Dis Clin N Am. 2015;29:211\u201339.","journal-title":"Infect Dis Clin N Am"},{"key":"1590_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.idc.2007.12.012","volume":"22","author":"P Dandache","year":"2008","unstructured":"Dandache P, Nadelman RB. Erythema migrans. Infect Dis Clin N Am. 2008;22:235\u201360.","journal-title":"Infect Dis Clin N Am"},{"key":"1590_CR9","unstructured":"Centers for Disease Control and Prevention. Lyme Disease (Borrelia burgdorferi) 2017 Case Definition. 2017. https:\/\/wwwn.cdc.gov\/nndss\/conditions\/lyme-disease\/case-definition\/2017\/."},{"key":"1590_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.7326\/0003-4819-136-6-200203190-00005","volume":"136","author":"RP Smith","year":"2002","unstructured":"Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL, et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med. 2002;136:421\u20138.","journal-title":"Ann Intern Med"},{"key":"1590_CR11","doi-asserted-by":"publisher","first-page":"S1475","DOI":"10.1093\/clinids\/11.Supplement_6.S1475","volume":"11","author":"BW Berger","year":"1989","unstructured":"Berger BW. Dermatologic manifestations of Lyme disease. Rev Infect Dis. 1989;11:S1475\u201381.","journal-title":"Rev Infect Dis"},{"key":"1590_CR12","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1001\/archderm.1992.01680210073010","volume":"128","author":"NS Goldberg","year":"1992","unstructured":"Goldberg NS, Forseter G, Nadelman RB, Schwartz I, Jorde U, McKenna D, et al. Vesicular erythema migrans. Arch Dermatol. 1992;128:1495\u20138.","journal-title":"Arch Dermatol"},{"key":"1590_CR13","unstructured":"Zajkowska J, Hermanowska-Szpakowicz T, Coyle P, Ostrowska J, Pancewicz S, Kondrusik M. Comparative study of early lyme disease: Erythema migrans in New York State and Northeastern Poland. Med Sci Monit. 2002;8."},{"key":"1590_CR14","doi-asserted-by":"crossref","unstructured":"Mazori DR, Orme CM, Mir A, Meehan SA, Neimann AL. Vesicular erythema migrans: an atypical and easily misdiagnosed form of Lyme disease. Dermatol Online J. 2015;21.","DOI":"10.5070\/D3218028428"},{"key":"1590_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.7326\/0003-4819-130-1-199901050-00006","volume":"130","author":"F Strle","year":"1999","unstructured":"Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med. 1999;130:32\u20136.","journal-title":"Ann Intern Med"},{"key":"1590_CR16","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1089\/vbz.2010.0230","volume":"11","author":"F Strle","year":"2011","unstructured":"Strle F, Ru\u017ei\u0107-Sablji\u0107 E, Logar M, Maraspin V, Lotri\u010d-Furlan S, Cimperman J, et al. Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii. Vector-Borne Zoonotic Dis. 2011;11:1253\u20138.","journal-title":"Vector-Borne Zoonotic Dis"},{"key":"1590_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/archderm.1993.01680270047005","volume":"129","author":"JW Melski","year":"1993","unstructured":"Melski JW, Reed KD, Mitchell PD, Barth GD. Primary and secondary erythema migrans in central Wisconsin. Arch Dermatol. 1993;129:709\u201316.","journal-title":"Arch Dermatol"},{"key":"1590_CR18","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nri3547","volume":"13","author":"AC Shaw","year":"2013","unstructured":"Shaw AC, Goldstein DR, Montgomery RR. Age-dependent dysregulation of innate immunity. Nat Rev Immunol. 2013;13:875\u201387.","journal-title":"Nat Rev Immunol"},{"key":"1590_CR19","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626\u201338.","journal-title":"Nat Rev Immunol"},{"key":"1590_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089\u2013134.","journal-title":"Clin Infect Dis"},{"key":"1590_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.7326\/0003-4819-99-1-76","volume":"99","author":"AC Steere","year":"1983","unstructured":"Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW, et al. The early clinical manifestations of Lyme disease. Ann Intern Med. 1983;99:76\u201382.","journal-title":"Ann Intern Med"},{"key":"1590_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0025-7125(03)00085-3","volume":"86","author":"J Edlow","year":"2002","unstructured":"Edlow J. Erythema migrans. Med Clin N Am. 2002;86:239\u201360.","journal-title":"Med Clin N Am"},{"key":"1590_CR23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2340\/00015555654352","volume":"65","author":"E Asbrink","year":"1985","unstructured":"Asbrink E, Olsson I. Clinical manifestations of erythema chronicum migrans Afzelius in 161 patients. A comparison with Lyme disease. Acta Derm Venereol. 1985;65:43\u201352.","journal-title":"Acta Derm Venereol."},{"key":"1590_CR24","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/jcm7120506","volume":"7","author":"K Bor\u0161i\u010d","year":"2018","unstructured":"Bor\u0161i\u010d K, Blagus R, Cerar T, Strle F, Stupica D. Clinical course, serologic response, and long-term outcome in elderly patients with early Lyme borreliosis. J Clin Med. 2018;7:506.","journal-title":"J Clin Med"},{"key":"1590_CR25","doi-asserted-by":"publisher","first-page":"e021367","DOI":"10.1136\/bmjopen-2017-021367","volume":"8","author":"AG Hirsch","year":"2018","unstructured":"Hirsch AG, Herman RJ, Rebman A, Moon KA, Aucott J, Heaney C, et al. Obstacles to diagnosis and treatment of Lyme disease in the USA: a qualitative study. BMJ Open. 2018;8:e021367.","journal-title":"BMJ Open"},{"key":"1590_CR26","doi-asserted-by":"crossref","unstructured":"Aucott JN, Crowder LA, Yedlin V, Kortte KB. Bull\u2019s-Eye and nontarget skin lesions of Lyme disease: an internet survey of identification of erythema migrans. Dermatol Res Pr. 2012;451727.","DOI":"10.1155\/2012\/451727"},{"key":"1590_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.7326\/0003-4819-136-6-200203190-00012","volume":"136","author":"RB Nadelman","year":"2002","unstructured":"Nadelman RB, Wormser GP. Recognition and treatment of erythema migrans: are we off target? Ann Intern Med. 2002;136:477\u20139.","journal-title":"Ann Intern Med"},{"key":"1590_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.diagmicrobio.2016.04.012","volume":"85","author":"E Weitzner","year":"2016","unstructured":"Weitzner E, Visintainer P, Wormser GP. Comparison of males versus females with culture-confirmed early Lyme disease at presentation and at 11\u201320 years after diagnosis. Diagn Microbiol Infect Dis. 2016;85:493\u20135.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1590_CR29","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.genm.2010.08.002","volume":"7","author":"A Schwarzwalder","year":"2010","unstructured":"Schwarzwalder A, Schneider MF, Lydecker A, Aucott JN. Sex differences in the clinical and serologic presentation of early Lyme disease: results from a retrospective review. Gend Med. 2010;7:320\u20139.","journal-title":"Gend Med"},{"key":"1590_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1089\/vbz.2006.0533","volume":"7","author":"L Bennet","year":"2007","unstructured":"Bennet L, Stjernberg L, Berglund J. Effect of gender on clinical and epidemiologic features of Lyme borreliosis. Vector Borne Zoonotic Dis. 2007;7:34\u201341.","journal-title":"Vector Borne Zoonotic Dis"},{"key":"1590_CR31","doi-asserted-by":"crossref","unstructured":"Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology. 2007;435\u2013436","DOI":"10.1111\/j.1365-2567.2007.02555.x"},{"key":"1590_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2334-9-79","volume":"9","author":"J Aucott","year":"2009","unstructured":"Aucott J, Morrison C, Munoz B, Rowe PC, Schwarzwalder A, West SK. Diagnostic challenges of early Lyme disease: lessons from a community case series. BMC Infect Dis. 2009;9:79.","journal-title":"BMC Infect Dis"},{"key":"1590_CR33","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1086\/432935","volume":"41","author":"GP Wormser","year":"2005","unstructured":"Wormser GP, Masters E, Nowakowski J, McKenna D, Holmgren D, Ma K, et al. Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions. Clin Infect Dis. 2005;41:958\u201365.","journal-title":"Clin Infect Dis"},{"key":"1590_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1089\/vbz.2018.2278","volume":"18","author":"DW Kannangara","year":"2018","unstructured":"Kannangara DW, Patel P. Report of non-lyme, erythema migrans rashes from New Jersey with a review of possible role of tick salivary toxins. Vector-Borne Zoonotic Dis. 2018;18:641\u201352.","journal-title":"Vector-Borne Zoonotic Dis"},{"key":"1590_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6622a1","volume":"66","author":"AM Schwartz","year":"2017","unstructured":"Schwartz AM, Hinckley AF, Mead PS, Hook SA, Kugeler KJ. Surveillance for Lyme disease\u2014United States, 2008\u20132015. MMWR Surveill Summ. 2017;66:1\u201312.","journal-title":"MMWR Surveill Summ"},{"key":"1590_CR36","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/bjd.17608","volume":"180","author":"JC Lester","year":"2019","unstructured":"Lester JC, Taylor SC, Chren M-M. Under-representation of skin of colour in dermatology images: not just an educational issue. Br J Dermatol. 2019;180:1521\u20132.","journal-title":"Br J Dermatol"},{"key":"1590_CR37","first-page":"e6509","volume":"11","author":"R Dennison","year":"2019","unstructured":"Dennison R, Novak C, Rebman A, Venkatesan A, Aucott J. Lyme disease with erythema migrans and seventh nerve palsy in an African-American man. Cureus. 2019;11:e6509.","journal-title":"Cureus"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-021-01590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-021-01590-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-021-01590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T17:01:36Z","timestamp":1697994096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-021-01590-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1590"],"URL":"https:\/\/doi.org\/10.1007\/s15010-021-01590-0","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,7]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs. Aucott\u00a0and Yang, and Mses. Rebman, Mihm, and Novak acknowledge grants to the study from the Steven & Alexandra Cohen Foundation, Global Lyme Alliance, and the Bay Area Lyme Foundation, as well as support from the National Center for Advancing Translational Science. The remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Institutional Review Board of the Johns Hopkins University School of Medicine approved this study. This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all individual participants included in this study prior to initiation of any study-related activities.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided written informed consent for publication of their images in Fig.\u00a0(panels a through g).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}